Literature DB >> 21587238

Pediatric rheumatology: Strengths and challenges of a new guide for treating JIA.

Philip J Hashkes.   

Abstract

Mesh：

Year:  2011        PMID： 21587238     DOI： 10.1038/nrrheum.2011.67

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  8 in total

1.  Tumor necrosis factor alpha blockers and malignancy in children: forty-eight cases reported to the Food and Drug Administration.

Authors:  Peter Diak; Jeffrey Siegel; Lois La Grenade; Lauren Choi; Steven Lemery; Ann McMahon
Journal:  Arthritis Rheum       Date:  2010-08

Review 2.  Dismantling the pyramid.

Authors:  J E Levinson; C A Wallace
Journal:  J Rheumatol Suppl       Date:  1992-04

3.  Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series.

Authors:  Peter A Nigrovic; Melissa Mannion; Femke H M Prince; Andrew Zeft; C Egla Rabinovich; Marion A J van Rossum; Elisabetta Cortis; Manuela Pardeo; Paivi M Miettunen; Ginger Janow; James Birmingham; Aaron Eggebeen; Erin Janssen; Andrew I Shulman; Mary Beth Son; Sandy Hong; Karla Jones; Norman T Ilowite; Randy Q Cron; Gloria C Higgins
Journal:  Arthritis Rheum       Date:  2011-02

Review 4.  Medical treatment of juvenile idiopathic arthritis.

Authors:  Philip J Hashkes; Ronald M Laxer
Journal:  JAMA       Date:  2005-10-05       Impact factor: 56.272

5.  Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial.

Authors:  Dirk Foell; Nico Wulffraat; Lucy R Wedderburn; Helmut Wittkowski; Michael Frosch; Joachim Gerss; Valda Stanevicha; Dimitrina Mihaylova; Virginia Ferriani; Florence Kanakoudi Tsakalidou; Ivan Foeldvari; Ruben Cuttica; Benito Gonzalez; Angelo Ravelli; Raju Khubchandani; Sheila Oliveira; Wineke Armbrust; Stella Garay; Jelena Vojinovic; Ximena Norambuena; María Luz Gamir; Julia García-Consuegra; Loredana Lepore; Gordana Susic; Fabrizia Corona; Pavla Dolezalova; Angela Pistorio; Alberto Martini; Nicolino Ruperto; Johannes Roth
Journal:  JAMA       Date:  2010-04-07       Impact factor: 56.272

Review 6.  2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features.

Authors:  Timothy Beukelman; Nivedita M Patkar; Kenneth G Saag; Sue Tolleson-Rinehart; Randy Q Cron; Esi Morgan DeWitt; Norman T Ilowite; Yukiko Kimura; Ronald M Laxer; Daniel J Lovell; Alberto Martini; C Egla Rabinovich; Nicolino Ruperto
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-04       Impact factor: 4.794

7.  Measuring process of arthritis care: a proposed set of quality measures for the process of care in juvenile idiopathic arthritis.

Authors:  Daniel J Lovell; Murray H Passo; Timothy Beukelman; Suzanne L Bowyer; Beth S Gottlieb; Michael Henrickson; Norman T Ilowite; Yukiko Kimura; Esi Morgan DeWitt; Jill Segerman; Leonard D Stein; Janalee Taylor; Richard K Vehe; Edward H Giannini
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-01       Impact factor: 4.794

8.  Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.

Authors:  Shumpei Yokota; Tomoyuki Imagawa; Masaaki Mori; Takako Miyamae; Yukoh Aihara; Shuji Takei; Naomi Iwata; Hiroaki Umebayashi; Takuji Murata; Mari Miyoshi; Minako Tomiita; Norihiro Nishimoto; Tadamitsu Kishimoto
Journal:  Lancet       Date:  2008-03-22       Impact factor: 79.321
  8 in total
  2 in total

Review 1.  JIA in 2011: New takes on categorization and treatment.

Authors:  Alberto Martini
Journal:  Nat Rev Rheumatol       Date:  2012-01-10       Impact factor: 20.543

2.  A Systematic Critical Appraisal of Clinical Practice Guidelines in Juvenile Idiopathic Arthritis Using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) Instrument.

Authors:  Christine A M Smith; Karine Toupin-April; Jeffrey W Jutai; Ciarán M Duffy; Prinon Rahman; Sabrina Cavallo; Lucie Brosseau
Journal:  PLoS One       Date:  2015-09-10       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.